Table 2.
Fasting Plasma Lipid, Glucose, and Insulin Data in Patients with PWS and Obese Individuals
| Laboratory Data | PWS Mean ± SD (N) |
Obese Mean ± SD (N) |
|---|---|---|
| Triglycerides (mg/dl) | 96.2 ± 67.0 (22) | 97.3 ± 61.8(32) |
| Total cholesterol (mg/dl) | 180.6 ± 46.5 (22) | 196.1 ± 53.9 (32) |
| HDL cholesterol (mg/dl) | 42.7 ± 12.9 (16) | 45.7 ± 14.2 (21) |
| LDL cholesterol (mg/dl) | 136.1 ± 32.6 (16) | 141.4 ± 62.1 (21) |
| Basal immunoreactive insulin (μU/ml) | 33.3 ± 35.7 (20)a | 24.9 ± 13.8 (17)a |
| Fasting glucose (mg/dl) | 113.6 ± 56.6 (11)a | 87.2 ± 7.4 (20) |
a
These values for both groups are outside the normative laboratory range. Three patients with PWS had fasting glucose levels greater than 150 mg/dl, while none of the obese individuals had values above 102 mg/dl.